A clinic should explain the treatment plan in detail, outline safety considerations, and provide transparent pricingclearly stating what is included, such as accommodation or airport transfer, and what is not
In a formal review, the agency concluded that BPC-157: Lacks sufficient safety data and has not been shown to be safe or effective in humans FDA Compounding Memorandum, 2023 The FDA also lists BPC-157 as ineligible for 503B compounding , which prohibits it from being added to compounded medications by outsourcing facilities
A fully virtual program with no in-person touchpoint should raise questions, especially for the first cycle
10.3748/wjg.v23.i29.5304 17 DrmicD.SamaraM.VidovicT.MalekinusicD.AntunovicM.VrdoljakB.et al (2018)
Mobile Abdominal Ultrasound AH by Desert Mobile Medical Clear Imaging
Comparative effectiveness of GLP1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis